1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Bulgaria Pharmaceuticals and Healthcare Report Q1 2016

Bulgaria Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 79 pages

Includes 3 FREE quarterly updates

BMI View: Pharmaceutical companies in Bulgaria will face increased pricing pressures from the NationalHealth Insurance Fund (NHIF) as it unveils more cost-containment measures to rein in pharmaceuticalexpenditure The NHIF will increasingly leverage its purchasing power to negotiate with drugmakers, andthis dynamic will moderate the growth outlook for the country's pharmaceutical sector

Headline Expenditure Projections
- Pharmaceuticals: BGN253bn (USD172bn) in 2014 to BGN271bn (USD152bn) in 2015; -70% inlocal currency terms and -115% in US dollar terms Forecast unchanged compared to the previousquarter
- Healthcare: BGN610bn (USD414bn) in 2014 to BGN632bn (USD355bn) in 2015; -36% in localcurrency terms and -142% in US dollar terms Forecast revised slightly downwards compared to theprevious quarter

Table Of Contents

Bulgaria Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Bulgaria 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bulgaria 2011-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2011-2019) 14
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2011-2019) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2011-2019) 15
Bulgaria 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019) 19
Bulgaria 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019) 22
Bulgaria 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Bulgaria 2013-2019) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Bulgaria 2013-2019) 27
Industry Risk Reward Ratings 28
Central And Eastern Europe Risk/Reward Index - Q1 2016 28
Bulgaria Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 39
Pricing Regime 40
Reimbursement Regime 43
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Bulgaria 2009-2014) 48
Table: Healthcare Resources (Bulgaria 2009-2014) 48
Table: Healthcare Personnel (Bulgaria 2009-2014) 48
Table: Healthcare Activity (Bulgaria 2009-2014) 49
Healthcare Sector 49
Table: NHIF Budget, 2014 53
Table: Bulgarian National Health Insurance Fund Revenues (BGN 000s), 2015 53
Research and Development 54
Table: Members Of ARPharM, 2014 54
Clinical Trials 55
Table: Cancer Incidence Rates, 2012-2035 57
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 59
Generic Drugmakers 60
Pharmaceutical Retail Sector 61
Wholesale Sector 62
Table: Pharmaceutical Wholesale And Retail Market, 2009-2012 63
Company Profile 64
Sopharma 64
Demographic Forecast 68
Demographic Outlook 68
Table: Population Headline Indicators (Bulgaria 1990-2025) 69
Table: Key Population Ratios (Bulgaria 1990-2025) 69
Table: Urban/Rural Population and Life Expectancy (Bulgaria 1990-2025) 70
Table: Population By Age Group (Bulgaria 1990-2025) 70
Table: Population By Age Group % (Bulgaria 1990-2025) 71
Glossary 73
Methodology 75
Pharmaceutical Expenditure Forecast Model 75
Healthcare Expenditure Forecast Model 75
Notes On Methodology 76
Risk/Reward Index Methodology 77
Index Overview 78
Table: Pharmaceutical Risk/Reward Index Indicators 78
Indicator Weightings 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.